On May 27th, 2025, the BRAV∃ project held its international symposium titled “BRAV3 SYMPOSIUM: New Frontiers in Cardiac Regenerative Medicine: From Computational and Beyond” at the Spanish National Centre for Cardiovascular Research (CNIC) in Madrid. The event brought together more than 120 participants, including leading researchers, clinicians, biomedical companies, SMEs, and patients, in a full-day programme dedicated to the latest advances in cardiac regenerative medicine.

The symposium was jointly organized by the project coordinator, Universidad de Navarra (UNAV), and CNIC, and represented a major milestone in the project’s efforts to share scientific results, promote interdisciplinary dialogue, and engage with broader society. Free and open to all, the event had been widely promoted for months in advance across research networks and institutional channels, drawing a diverse and international audience.

Structured around the core thematic areas of the BRAV∃ project, the agenda combined presentations by the project’s Work Package leaders—who shared the most relevant scientific achievements to date—with talks by five distinguished keynote speakers from across Europe, selected for their expertise in key fields of the project:

  • Philippe Menasché (Hôpital Européen Georges-Pompidou, France)
  • João Mano (Aveiro Institute of Materials, Portugal)
  • Felix Engel (Erlangen University Hospital, Germany)
  • Julia Neubauer (Fraunhofer Institute, Germany)
  • Malte Tiburcy (University Medical Center Göttingen, Germany)

The programme was carefully designed to alternate project-focused sessions with external expert insights, offering both depth and cross-disciplinary perspective. This format proved highly successful, with attendees praising the scientific quality and relevance of the content presented.

In addition to advancing scientific exchange, the event reinforced the BRAV∃ consortium’s commitment to open science and societal impact. The symposium served as a platform not only for showcasing research but also for dialogue with patients and the public, particularly those affected by cardiovascular conditions.